You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the first-line treatment of stage III-IV follicular lymphoma

  • Technology appraisal guidance
  • Reference number: TA243
  • Published:  25 January 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Rituximab for first-line treatment of stage III–IV follicular lymphoma (PDF 167 KB)

    Published:
    25 January 2012
  • Gwybodaeth i'r cyhoedd (Word 247 KB)

    Published:
    01 June 2012
Back to top